insurance dropping glp 1 Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases GLP-1 insurance change impacts millions
Description
Neoadjuvant Setting: Specifically, caution is advised for patients using GLP-1 RAs during neoadjuvant regimens like the phase 3 KEYNOTE-522 trial (NCT03036488)
10, Table 2)
Limit showers to just 5-10 minutes, and use warm water to help avoid dry skin
Briefly touch upon potential legal complications surrounding the sale of compounded GLP-1s online
The arrival of effective pharmacotherapy changes the clinical calculus, but the pediatric literature is thinner than the adult data, and some of the questions most relevant to long-term prescribing remain unanswered
